// App-Quantinova.ai

: REPAIR: long-term effects of macitentan on the right ventricle (RV in pulmonary arterial hypertension (PAH

Researchers

Presenter

  • David Kiely

Principal Investigators

  • Emmanuelle Cottreel

  • Nazzareno Galiè

  • J. Tim Marcus

  • Andrew Peacock

  • Stephan Rosenkranz

  • Andrew J Swift

  • Ahmed Tawakol

  • Adam Torbicki

  • Anton Vonk Noordegraaf

  • Graham Wetherill

  • Richard Channick

Medical Centers

  • Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom,

  • Actelion Pharmaceuticals Ltd, Allschwil, Switzerland

  • Department of Experimental, Diagnostic and Specialty Medicine. University of Bologna, Bologna, Italy.

  • Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

  • Scottish Pulmonary Vascular Unit, Glasgow, United Kingdom.

  • Heart Center at the University of Cologne, and Cologne Cardiovascular Research Center (CCRC, Cologne, Germany

  • Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom,

  • Massachusetts General Hospital and Harvard Medical School, Boston, United States of America

  • Department of Pulmonary Circulation CMKP at European Health Center, Otwock, Poland

  • UCLA David Geffen School of Medicine, Rheumatology, Los Angeles, United States of America

Locations

  • United Kingdom

  • Switzerland

  • Italy

  • Netherlands

  • Germany

  • United States

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • N/A

Drug/Treatment

  • macitentan

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

  • Multicenteric

Phase

  • IV

Study Id's

  • NCT02310672

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved